Medicare Benefits Schedule - Note TN.8.136

Search Results for Note TN.8.136

View Related Items

Category 3 - THERAPEUTIC PROCEDURES

TN.8.136

Corneal Collagen Cross Linking (Item 42652)

Evidence of progression in patients over the age of twenty five is determined by the patient history including an objective change in tomography or refraction over time. Evidence of progression in patients aged twenty five years or younger is determined by patient history including an objective change in tomography or refraction over time and/or posterior elevation data and objective documented progression at a subclinical level.

Related Items: 42652


Related Items

Category 3 - THERAPEUTIC PROCEDURES

42652

42652 - Additional Information

Item Start Date:
01-May-2018
Description Updated:
01-Jul-2021
Schedule Fee Updated:
01-Nov-2023

Corneal collagen cross linking, on a patient with a corneal ectatic disorder, with evidence of progression—per eye

(Anaes.)

Fee: $1,320.85 Benefit: 75% = $990.65 85% = $1,222.15

(See para TN.8.136 of explanatory notes to this Category)


Legend

  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change